Flaviviridae · Hepacivirus
| Alisporivir | HCV | — | Phase 3 | — | Human CYPs | |
| Cyclosporine | HCV | Calcineurin inhibitor; allows for inhibition of T cell activation | Phase 3 | — | Human CYPs | |
| Ezetimibe | HCV | Intestinal cholesterol and related phytosterol absorption inhibitor | Phase 3 | — | Human cholesterol transporter | |
| Nitazoxanide | HCV | Pyruvate inhibitor | Phase 3 | — | Human pyruvate synthase | |
| Sofosbuvir | HCV | Nucleotide analog inhibitor of HCV NS5B RNA-dependent RNA polymerase | FDA approved | FDAJapanChina | Viral RNA pol | |
| Thymalfasin | HCV | Th1 cell stimulant; Th2 cell inhibitor; Th2 cell modulator | FDA approved | FDA | Unknown | |
| Telaprevir | HCV | — | FDA approved | FDAJapan | NS3/4A protease | |
| Boceprevir | HCV | NS3/4a protease inhibitor | FDA approved | FDA | NS3/4A protease | AntiviralDbDB08873 |
| Simeprevir | HCV | Recovers host IFN signaling | FDA approved | FDAJapan | NS3/4A protease | |
| Asunaprevir | HCV | — | FDA approved | FDAJapan | NS3/4A protease | |
| Vaniprevir | HCV | — | FDA approved | FDAJapan | NS3/4A protease | AntiviralDbpmda.go.jp |
| Paritaprevir | HCV | — | FDA approved | FDAJapan | NS3/4A protease | |
| Grazoprevir | HCV | — | FDA approved | FDAJapan | NS3/4A protease | |
| Voxilaprevir | HCV | — | FDA approved | FDA | NS3/4A protease | AntiviralDb |
| Glecaprevir | HCV | — | FDA approved | FDAJapan | NS3/4A protease | |
| Ledipasvir | HCV | — | FDA approved | FDAJapan | NS5A phosphoprotein | |
| Ombitasvir | HCV | — | FDA approved | FDAJapan | NS5A phosphoprotein | |
| Ribavirin | HCV | Nucleoside inhibitor; Guanosine (ribonucleic) analog | FDA approved | FDAJapanChinaRussia | NS5A phosphoprotein | |
| Daclatasvir | HCV | Blocks intracellular viral RNA synthesis | FDA approved | FDAJapan | NS5A phosphoprotein | |
| Elbasvir | HCV | — | FDA approved | FDAJapan | NS5A phosphoprotein | |
| Pibrentasvir | HCV | — | FDA approved | FDAJapan | NS5A phosphoprotein | |
| Velpatasvir | HCV | — | FDA approved | FDAJapan | NS5A phosphoprotein | |
| Dasabuvir | HCV | — | FDA approved | FDA | NS5B polymerase | AntiviralDb |
| uprifosbuvir | HCV | — | Phase 2 | — | — | |
| faldaprevir | HCV | — | Phase 2 | — | — |